Organigram Global Inc. vs Pfizer, Inc. — Stock Comparison

OGI
Organigram Global Inc.
$1.42
▲ 0.71%
vs
PFE
Pfizer, Inc.
$26.33
▼ 1.39%
Q·Score Winner
Pfizer, Inc.
PFE6.5/10vs 6.1/10

Q·Score Breakdown

6.1
Neutral
Overall
6.5
Neutral
3.6
Quality
7.4
8.4
Health
7
6.7
Growth
5.6
4.9
Valuation
6.7
8.3
Sentiment
5.2
OGI

Clean balance sheet with low leverage (0.0× debt-to-equity).

low return on equity (5%).

PFE

Strong profitability with 12% net profit margins.

analyst sentiment is cautious.

Analyst Consensus

BUY
0 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts

Fundamentals

OGI
PFE
12.9×
Trailing P/E
19.4×
59.2×
Forward P/E
9.4×
6.5%
Profit Margin
12.4%
35.6%
Gross Margin
75.8%
4.6%
ROE
8.9%
48.7%
Revenue Growth
-1.2%
Earnings Growth
1.87
Beta
0.39
Price / Book
$200M
Market Cap
$149.8B
$1 – $2
52-Week Range
$22 – $29

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →